Clinical Trial Update: A Study of Oral Tetrahydrouridine-Decitabine in Relapsed or Refractory Myelodysplastic Syndromes (MDS) [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating an oral tetrahydrouridine-decitabine combination for relapsed or refractory myelodysplastic syndromes is currently recruiting, sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Decitabine (Decitabine)
• Tetrahydrouridine (tetrahydrouridine)

Snippet

Sponsor: Treebough Therapies | Conditions: MDS | Phase 1 | Status: RECRUITING